Medical Research and Clinical Trials

Unmasking Cancer’s Neural Deception: OU Researchers Uncover How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

• Medical Research and Clinical Trials

Unmasking Cancer’s Neural Deception: OU Researchers Uncover How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Suro Senen October 22, 2026

Oklahoma City, OK – In a significant breakthrough that could redefine the battle against aggressive cancers, new...

Read More Read more about Unmasking Cancer’s Neural Deception: OU Researchers Uncover How Aggressive Breast Cancer Hijacks the Immune System to Fuel Growth

Groundbreaking Clinical Trial Launched to Combat Post-Treatment Lyme Disease Syndrome

• Medical Research and Clinical Trials

Groundbreaking Clinical Trial Launched to Combat Post-Treatment Lyme Disease Syndrome

Layla Zulfa October 22, 2026

A novel approach targeting persistent immune dysfunction in PTLDS patients marks a significant step forward in addressing...

Read More Read more about Groundbreaking Clinical Trial Launched to Combat Post-Treatment Lyme Disease Syndrome

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth, Offers Novel Therapeutic Pathway

• Medical Research and Clinical Trials

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth, Offers Novel Therapeutic Pathway

Asro October 22, 2026

Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...

Read More Read more about Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth, Offers Novel Therapeutic Pathway

Hope on the Horizon: HealthBio Launches Pivotal Trial for Post-Treatment Lyme Disease Syndrome

• Medical Research and Clinical Trials

Hope on the Horizon: HealthBio Launches Pivotal Trial for Post-Treatment Lyme Disease Syndrome

Iffa Jayyana October 22, 2026

A groundbreaking clinical trial, HBT-002, initiated by US-based biotechnology firm HealthBio, is poised to offer a new...

Read More Read more about Hope on the Horizon: HealthBio Launches Pivotal Trial for Post-Treatment Lyme Disease Syndrome

Groundbreaking Research Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Research Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Suro Senen October 22, 2026

Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...

Read More Read more about Groundbreaking Research Reveals How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Duvakitug Poised to Differentiate in Inflammatory Bowel Disease Race as New Data Show Promising Efficacy and Safety

• Medical Research and Clinical Trials

Duvakitug Poised to Differentiate in Inflammatory Bowel Disease Race as New Data Show Promising Efficacy and Safety

Asep Darmawan October 22, 2026

Sanofi and Teva Pharmaceuticals’ investigational therapy, duvakitug, is emerging as a significant contender in the increasingly competitive...

Read More Read more about Duvakitug Poised to Differentiate in Inflammatory Bowel Disease Race as New Data Show Promising Efficacy and Safety

Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth

• Medical Research and Clinical Trials

Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth

Neng Nana October 21, 2026

NORMAN, OK – In a significant breakthrough poised to redefine our understanding of cancer progression and treatment,...

Read More Read more about Unraveling Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Tumors Hijack the Immune System to Fuel Growth

Duvakitug Emerges as a Promising Contender in the Inflammatory Bowel Disease Race, Analysts Highlight Differentiating Factors

• Medical Research and Clinical Trials

Duvakitug Emerges as a Promising Contender in the Inflammatory Bowel Disease Race, Analysts Highlight Differentiating Factors

Nana Muazin October 21, 2026

Sanofi and Teva Pharmaceuticals’ investigational therapy, duvakitug, has demonstrated significant clinical benefits in patients suffering from moderate-to-severe...

Read More Read more about Duvakitug Emerges as a Promising Contender in the Inflammatory Bowel Disease Race, Analysts Highlight Differentiating Factors

Duvakitug Emerges as a Potential Differentiator in the Heated Race for Inflammatory Bowel Disease Therapies

• Medical Research and Clinical Trials

Duvakitug Emerges as a Potential Differentiator in the Heated Race for Inflammatory Bowel Disease Therapies

Laily UPN October 21, 2026

Sanofi and Teva Pharmaceuticals’ investigational anti-TL1A therapy, duvakitug, has demonstrated significant promise in treating both ulcerative colitis...

Read More Read more about Duvakitug Emerges as a Potential Differentiator in the Heated Race for Inflammatory Bowel Disease Therapies

Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets

• Medical Research and Clinical Trials

Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets

Layla Zulfa October 21, 2026

Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...

Read More Read more about Breakthrough in Breast Cancer Research: Unveiling a Novel Mechanism of Tumor Growth and Potential Therapeutic Targets